StockTipsArenaBeta

BUY IPCA Laboratories Limited — Nuvama Wealth

BUYIPCA Laboratories Limited
IPCA Laboratories share price target & all analyst calls

byNuvama WealthHorizon: NA (inferred 1 year)17 Aug 2026via ET Now (Live)

Entry₹1,805.9Inferred
Target₹2,025
Total upside +12.13% (call closed)
Stop lossNot given
Exit₹2,02518 Sept 2026, 12:09 pm
Target hit+12.13%0.00%upside left
Follow Nuvama Wealth for new calls(69% target hit, 144 closed calls)Get alertsWatch IPCALAB for new buy/sell callsGet alertsSee 1 active Long-term call on IPCALABSee 212 active Long-term picks this week

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

Frozen at close · 18 Sept 2026
21 supporting5 neutral6 opposing
Supports the BUY call (21)

Ipca Labs Rallies 50% on Q1 Growth; Analysts Flag Valuation Limits

NewsGoogle News·16 Sept · yesterday

(opens in new tab)

Krebs Biochemicals భారీ నష్టం.. Ipca Labs తో విలీనానికి గ్రీన్ సిగ్నల్!

NewsGoogle News·4 Sept · 2w ago

(opens in new tab)

Elara initiates coverage on Alkem, Eris, IPCA and Mankind. Check ratings and targets

NewsEt-Markets·28 Aug · 3w ago

(opens in new tab)

Lyka Labs standalone profit surges 159% in Q1FY27 on export strength

NewsGoogle News·23 Aug · 4w ago

(opens in new tab)

3 advisors have active short-term BUY calls on this stock

Advisor consensus · adjacent horizon·18 Aug · 1mo ago

Neutral / worth noting (5)

Nothing found in this tip’s window yet.

Weighs against the BUY call (6)

Nothing found in this tip’s window yet.

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

Other calls on IPCA Laboratories

All analyst calls on IPCA Laboratories

More from Nuvama Wealth

Every call and its outcome